Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Alopecia
ADR ID BADD_A00152
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.02      Alopecias
23.02.02.001      Alopecia
Description A disorder characterized by a decrease in density of hair compared to normal for a given individual at a given age and body location. [CTCAE] Absence of hair from areas where it is normally present. [MeSH]
MedDRA Code 10001760
MeSH ID D000505; D000505; D000505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Accelerated hair loss | Alopecia | Alopecia reversible | Alopecia, unspecified | Atrichia | Atrichosis | Baldness | Frontal-parietal thinning | Hair loss | Hair thinning | Other alopecia | Body hair loss | Traction alopecia | Alopecia post chemotherapy | Hair Loss | Hair Losses | Loss, Hair | Losses, Hair | Alopecia, Male Pattern | Male Pattern Alopecia | Baldness, Male Pattern | Male Pattern Baldness | Female Pattern Baldness | Baldness, Female Pattern | Androgenetic Alopecia | Pattern Baldness | Baldness, Pattern | Androgenic Alopecia | Alopecia, Androgenic | Alopecias, Androgenic | Androgenic Alopecias | Alopecia, Androgenetic | Pseudopelade | Alopecia Cicatrisata | Alopecia Cicatrisatas
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02486Niraparib0.002131%
BADD_D02487Baricitinib0.001737%
BADD_D02489Neratinib--
BADD_D02490Apalutamide--
BADD_D02491Valbenazine--
BADD_D02492Deflazacort--
BADD_D02496Elagolix0.025483%
BADD_D02498Abemaciclib0.005861%
BADD_D02500Alpelisib--
BADD_D02507Deutetrabenazine0.003921%
BADD_D02510Rucaparib0.008792%
BADD_D02511Siponimod0.002316%
BADD_D02513Pegvaliase0.021361%
BADD_D02514Etelcalcetide--
BADD_D02515Pexidartinib0.000533%
BADD_D02518Semaglutide--
BADD_D02522Lithium citrate--
The 28th Page    First    Pre   28    Total 28 Pages